Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
32.73
-0.02 (-0.06%)
May 9, 2025, 11:21 AM - Market open

Ionis Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
264.19242.08399.27276.47869.19397.66
Upgrade
Short-Term Investments
1,8842,0611,9381,7211,2641,501
Upgrade
Cash & Short-Term Investments
2,1482,3032,3381,9972,1331,899
Upgrade
Cash Growth
-3.00%-1.48%17.03%-6.37%12.32%-24.30%
Upgrade
Receivables
39.7192.1997.7825.5461.976.2
Upgrade
Inventory
11.512.517.4422.0324.8121.97
Upgrade
Other Current Assets
219.49212.67199.13157.72125.17133.42
Upgrade
Total Current Assets
2,4192,6202,6422,2032,3452,131
Upgrade
Property, Plant & Equipment
262.19256.11242.94255.84196.04181.08
Upgrade
Long-Term Investments
41.0241.0242.9940.3732.3215.06
Upgrade
Other Intangible Assets
-----27.94
Upgrade
Other Long-Term Assets
90.886.2662.2934.9738.2834.97
Upgrade
Total Assets
2,8133,0042,9902,5342,6122,390
Upgrade
Accounts Payable
17.4642.9626.0317.9211.917.2
Upgrade
Accrued Expenses
129.31178.05215.62189.28127.37155.89
Upgrade
Current Portion of Long-Term Debt
22.30.2245.070.320.9316.11
Upgrade
Current Portion of Leases
-9.068.097.222.63-
Upgrade
Current Income Taxes Payable
0.130.032.156.250.041.32
Upgrade
Current Unearned Revenue
81.178.99151.1390.5897.71108.38
Upgrade
Total Current Liabilities
250.29309.32448.09311.56240.55598.9
Upgrade
Long-Term Debt
1,7871,7881,7431,1831,228623.53
Upgrade
Long-Term Leases
159.39161.81170.88178.9419.43-
Upgrade
Long-Term Unearned Revenue
140.68156.5241.18287.77351.88424.05
Upgrade
Total Liabilities
2,3372,4152,6031,9611,8401,646
Upgrade
Common Stock
0.160.160.140.140.140.14
Upgrade
Additional Paid-In Capital
2,9012,8692,2152,0601,9641,896
Upgrade
Retained Earnings
-2,397-2,250-1,796-1,430-1,160-1,131
Upgrade
Comprehensive Income & Other
-28.95-30.81-32.65-57.48-32.67-21.07
Upgrade
Total Common Equity
475.73588.35386.69572.89771.74743.28
Upgrade
Shareholders' Equity
475.73588.35386.69572.89771.74743.28
Upgrade
Total Liabilities & Equity
2,8133,0042,9902,5342,6122,390
Upgrade
Total Debt
1,9691,9591,9671,3691,251939.64
Upgrade
Net Cash (Debt)
179.68344.14370.23628.21882.13959.48
Upgrade
Net Cash Growth
-23.75%-7.05%-41.07%-28.78%-8.06%-44.26%
Upgrade
Net Cash Per Share
1.182.302.594.436.266.87
Upgrade
Filing Date Shares Outstanding
159.16158.96145.75142.95141.69140.86
Upgrade
Total Common Shares Outstanding
159.04157.91144.34142.06141.21140.37
Upgrade
Working Capital
2,1692,3112,1941,8912,1041,532
Upgrade
Book Value Per Share
2.993.732.684.035.475.30
Upgrade
Tangible Book Value
475.73588.35386.69572.89771.74715.35
Upgrade
Tangible Book Value Per Share
2.993.732.684.035.475.10
Upgrade
Land
-8.578.578.5723.0623.06
Upgrade
Buildings
-41.2341.2341.16144.05137.88
Upgrade
Machinery
-9.869.849.5810.5912.87
Upgrade
Leasehold Improvements
-54.3828.2828.3620.1417.26
Upgrade
Updated Apr 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q